
Tezepelumab is the first biologic medication to show a reduction in severe asthma symptoms.
Marissa Fox is the Assistant Editor of Drug Topics ®.

Tezepelumab is the first biologic medication to show a reduction in severe asthma symptoms.

A new medication called finerenone (Kerendia; Bayer) has been approved for the treatment of kidney disease and type 2 diabetes.

An assessment tool called the objective structured clinical examination has been shown to improve pharmacy education for students.

Patients with cancer with complete COVID-19 vaccinations demonstrated a high rate of antibodies, according to the study.

Kenrik Duru, MD, MSHS presented a model of future projections of Medi-Cal on Diabetes Prevention Programs through current performance measures and struggles identified.

Educating families to alleviate fear in pediatric populations regarding the flu vaccine will improve the vaccination rate and protect high-risk children. Due to the negative effects of the flu in children with diabetes, it is vital that at-risk youth be vaccinated.

Study results showed there was no significant correlation between blood glucose levels and mortality or the rate of stay in intensive care units of hospitals for sick patients with diabetes, pneumonia, and COVID-19.

Blood-brain barrier crossing medicines have shown memory benefits in elderly patients, according to a new analysis.

There was a marked decline in child and adolescent routine vaccine administration during the COVID-19 pandemic between March and September 2020; these vaccination rates have continued to lag behind.